Oragenics, Inc.
OGEN · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $4 | $15 | $10 | $11 |
| G&A Expenses | $6 | $5 | $4 | $5 |
| SG&A Expenses | $6 | $5 | $4 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | -$0 | -$0 |
| Operating Expenses | $11 | $21 | $14 | $16 |
| Operating Income | -$11 | -$21 | -$14 | -$16 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | $0 | $0 | $0 |
| Pre-Tax Income | -$11 | -$21 | -$14 | -$16 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11 | -$21 | -$14 | -$16 |
| % Margin | – | – | – | – |
| EPS | -1.6 | -9.18 | -7.11 | -8.09 |
| % Growth | 82.6% | -29.1% | 12.1% | – |
| EPS Diluted | -1.6 | -9.18 | -7.11 | -8.09 |
| Weighted Avg Shares Out | 7 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 7 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$11 | -$21 | -$14 | -$16 |
| % Margin | – | – | – | – |